Atara Biotherapeutics (ATRA) P/E (2014 - 2026)
Atara Biotherapeutics (ATRA) P/E from Oct 16, 2014 to Jul 21, 2026. The TTM Atara Biotherapeutics (ATRA) P/E is -7.16. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Atara Biotherapeutics (ATRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -7.16 | -325.38% |
| 2025 | 3.18 | -492.80% |
| 2024 | -0.81 | +363.49% |
| 2023 | -0.17 | -85.90% |
| 2022 | -1.24 | -69.42% |
| 2021 | -4.04 | -12.89% |
| 2020 | -4.64 | +61.44% |
| 2019 | -2.88 | -57.89% |
| 2018 | -6.83 | +8.05% |
| 2017 | -6.32 | +27.46% |
| 2016 | -4.96 | -59.30% |
| 2015 | -12.19 | -24.63% |
| 2014 | -16.17 | N/A |
Comparison Atara Biotherapeutics (ATRA) P/E with competitors
Atara Biotherapeutics (ATRA) P/E is -7.16.